Goetz Kathleen

Goetz Kathleen is listed in filings as Director at Aurinia Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through May 16, 2025, including 1 public disclosure. Recent filings connect the profile to Aurinia Pharmaceuticals Inc. (AUPH). The current snapshot covers public activity from May 16, 2025. Reported amounts are shown as $519.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.